What the agency says to do
FDA’s record gives no instruction for consumers.
Status: Ongoing. What the FDA’s recall statuses mean (opens in a new tab)
Note from Recalls Watch, not agency text
- Talk to your pharmacist or doctor before you stop taking a medicine. FDA: Medication Guides and your medicines (opens in a new tab)
- In an emergency call 911. For a possible poisoning call Poison Help at 1-800-222-1222. Poison Help (HRSA) (opens in a new tab)
- For refunds, repairs or replacements, follow the agency notice. Recalls.gov (opens in a new tab)
Why it was recalled
CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
FDA classification: Class II. What the FDA’s classes mean (opens in a new tab)
The recalled product
Codes in the record. Click one to copy it.
Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.
- Lot or code
- Lot # 222205C, exp. date 11/2025
- FDA recall number
- D-0161-2025
- Quantity
- 163,883 bottles
Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 90-count bottles (NDC 51991-748-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.
- Lot or code
- Lot # 230077C, exp. date 11/2025
- FDA recall number
- D-0162-2025
- Quantity
- 76,968 bottles
Distribution (FDA): Nationwide in the US
Source
- Issued by
- U.S. Food and Drug Administration
- Firm
- Breckenridge Pharmaceutical, Inc
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.